Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.
about
The biomarkers of immune dysregulation and inflammation response in Parkinson diseaseNovel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTORErythropoietin and diabetes mellitusFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.WISP1: Clinical insights for a proliferative and restorative member of the CCN familyEnhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells.Nurr1-Based Therapies for Parkinson's Disease.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Melatonin-mediated β-catenin activation protects neuron cells against prion protein-induced neurotoxicity.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.The potential role of neuroinflammation and transcription factors in Parkinson diseaseUp-Regulation of Corticocerebral NKD2 in Lipopolysaccharide-Induced Neuroinflammation.Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function.Downregulation of the Wnt/β-catenin signaling pathway is involved in manganese-induced neurotoxicity in rat striatum and PC12 cells.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson's disease.SOX7 interferes with β-catenin activity to promote neuronal apoptosis.Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson's Disease via Up-regulation of the Wnt/β-Catenin Pathway.Melatonin Inhibits Neural Cell Apoptosis and Promotes Locomotor Recovery via Activation of the Wnt/β-Catenin Signaling Pathway After Spinal Cord Injury.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.FoxO proteins in the nervous system.
P2860
Q26738459-6B67758F-27EC-4C25-850D-93F223A222D6Q26749047-5B8DA300-5A03-4FE3-BE3E-5511F87F0383Q26777878-F6010688-875E-4C53-A9A3-55CACBFDC1BDQ26800615-B7FB4A7D-E19B-422A-89E0-098A34202938Q28066377-59B2CDC0-65D0-4D01-87A5-AD8E65FDE1ABQ28080679-31044376-8796-4F65-BB0B-89B73A93359DQ28085715-6E5338BC-5AFF-4F8A-80C3-6D247A69233CQ33593798-6C7B3481-7018-4734-9F1F-F80E706D344DQ33771694-6951F923-CFB5-4DC9-BF1F-1AA31B3C51DDQ34381111-B2D76568-5C5E-40E5-8BFB-9AEC54F35CE9Q34520848-355477C1-3C73-4324-A73E-0A2B6473DB81Q35325532-232041CF-0675-4AAA-A863-1EB965B76573Q36803630-522CF77A-9C3B-4237-8357-A2C0E9D9945AQ38367977-8E20E7E8-7B3B-4BD4-928A-D6366337978FQ38433760-70328318-3717-4015-A557-199931E2E3E0Q38607849-CC2D3089-9DA1-4C04-8A28-0FFD88BB4509Q38743109-C359EFC8-2F26-47F8-A214-F3D1AC4E5E44Q39037684-3F229C22-7F91-4623-849B-C10011C6C3B6Q39342497-F162188B-88AE-4EFE-82BD-DB6EB90F3890Q40826337-6317A40F-CAB0-49B3-9BCA-9C6120F07787Q42428091-5943D3FF-5B63-435F-A2F0-8E3DA7A3EA48Q42707173-60F2B99C-2BD2-4F68-9209-C25041FEC0EEQ43679571-3911BB30-B2BF-474E-A7AA-BAB187CB4EFDQ46465276-7A0E9537-465A-48C1-A7F5-505652685B15Q48244229-36408F63-9163-45D6-A671-70B13630409FQ49408164-8381C23C-5699-47B3-ABC7-CFDF76AFBB75Q51052629-C46C4644-6CD0-43ED-B4E6-6720C114264CQ51761339-0AF47BFB-9223-4F44-AF16-9D64EFCBD9F6Q51767077-17BEA4DD-F747-4B55-B74C-B028EE620E76Q52361076-3270F6CA-736D-49F0-B10F-8DB5D2D937EBQ53622309-EB074393-C2EE-4B0D-9AB6-E621CE0CCBFE
P2860
Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@en
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@nl
type
label
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@en
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@nl
prefLabel
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@en
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@nl
P2093
P2860
P1476
Activation of Wnt/β-catenin pa ...... st 6-hydroxydopamine toxicity.
@en
P2093
Congcong Sun
Feifei Luo
Shaomin Li
P2860
P2888
P304
P356
10.1007/S12031-012-9900-8
P577
2012-10-11T00:00:00Z